Literature DB >> 34038425

Launching a saliva-based SARS-CoV-2 surveillance testing program on a university campus.

Alexander J Ehrenberg1,2, Erica A Moehle1,2, Cara E Brook1,2, Andrew H Doudna Cate1, Lea B Witkowsky1,2, Rohan Sachdeva1,2, Ariana Hirsh1,2, Kerrie Barry3, Jennifer R Hamilton1,2, Enrique Lin-Shiao1,2, Shana McDevitt1,2, Luis Valentin-Alvarado1,2, Kaitlyn N Letourneau1, Lauren Hunter1, Amanda Keller2, Kathleen Pestal1, Phillip A Frankino1, Andrew Murley1, Divya Nandakumar1,2, Elizabeth C Stahl1,2, Connor A Tsuchida1,2, Holly K Gildea1, Andrew G Murdock1,2, Megan L Hochstrasser2, Elizabeth O'Brien1,2, Alison Ciling1,2, Alexandra Tsitsiklis1, Kurtresha Worden1,2, Claire Dugast-Darzacq1, Stephanie G Hays1, Colin C Barber1, Riley McGarrigle1,2, Emily K Lam1, David C Ensminger1, Lucie Bardet2, Carolyn Sherry2, Anna Harte1,4, Guy Nicolette1,4, Petros Giannikopoulos2, Dirk Hockemeyer1,2,5, Maya Petersen1, Fyodor D Urnov1,2, Bradley R Ringeisen1,2, Mike Boots1, Jennifer A Doudna1,2,6.   

Abstract

Regular surveillance testing of asymptomatic individuals for SARS-CoV-2 has been center to SARS-CoV-2 outbreak prevention on college and university campuses. Here we describe the voluntary saliva testing program instituted at the University of California, Berkeley during an early period of the SARS-CoV-2 pandemic in 2020. The program was administered as a research study ahead of clinical implementation, enabling us to launch surveillance testing while continuing to optimize the assay. Results of both the testing protocol itself and the study participants' experience show how the program succeeded in providing routine, robust testing capable of contributing to outbreak prevention within a campus community and offer strategies for encouraging participation and a sense of civic responsibility.

Entities:  

Year:  2021        PMID: 34038425     DOI: 10.1371/journal.pone.0251296

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  10 in total

1.  COVID-19 active case findings based on self-collected saliva samples with CRISPR-Cas12a detection.

Authors:  Naphat Chantaravisoot; Pornchai Kaewsapsak; Oraphan Mayuramart; Pattaraporn Nimsamer; Suwanan Mankhong; Nantinee Chomta; Rungnapa Bootsri; Isara Alee; Piriya Wongkongkathep; Sombat Treeprasertsuk; Sunchai Payungporn
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-27

2.  Optimizing COVID-19 control with asymptomatic surveillance testing in a university environment.

Authors:  Cara E Brook; Graham R Northrup; Alexander J Ehrenberg; Jennifer A Doudna; Mike Boots
Journal:  Epidemics       Date:  2021-11-15       Impact factor: 5.324

3.  A method for campus-wide SARS-CoV-2 surveillance at a large public university.

Authors:  Terren Chang; Jolene M Draper; Anouk Van den Bout; Ellen Kephart; Hannah Maul-Newby; Yvonne Vasquez; Jason Woodbury; Savanna Randi; Martina Pedersen; Maeve Nave; Scott La; Natalie Gallagher; Molly M McCabe; Namrita Dhillon; Isabel Bjork; Michael Luttrell; Frank Dang; John B MacMillan; Ralph Green; Elizabeth Miller; Auston M Kilpatrick; Olena Vaske; Michael D Stone; Jeremy R Sanford
Journal:  PLoS One       Date:  2021-12-17       Impact factor: 3.752

4.  Acceptability of Community Saliva Testing in Controlling the COVID-19 Pandemic: Lessons Learned from Two Case Studies in Nursing Homes and Schools.

Authors:  Benoit Pétré; Marine Paridans; Nicolas Gillain; Eddy Husson; Anne-Françoise Donneau; Nadia Dardenne; Christophe Breuer; Fabienne Michel; Margaux Dandoy; Fabrice Bureau; Laurent Gillet; Dieudonné Leclercq; Michèle Guillaume
Journal:  Patient Prefer Adherence       Date:  2022-03-04       Impact factor: 2.711

5.  Food for thought: Eating before saliva collection and interference with SARS-CoV-2 detection.

Authors:  Matthew M Hernandez; Mariawy Riollano-Cruz; Mary C Boyle; Radhika Banu; Paras Shrestha; Brandon Gray; Liyong Cao; Feng Chen; Huanzhi Shi; Daniel E Paniz-Perez; Paul A Paniz-Perez; Aryan L Rishi; Jacob Dubinsky; Dylan Dubinsky; Owen Dubinsky; Sophie Baine; Lily Baine; Suzanne Arinsburg; Ian Baine; Juan David Ramirez; Carlos Cordon-Cardo; Emilia Mia Sordillo; Alberto E Paniz-Mondolfi
Journal:  J Med Virol       Date:  2022-02-23       Impact factor: 20.693

6.  Identifying SARS-CoV-2 Variants of Concern through Saliva-Based RT-qPCR by Targeting Recurrent Mutation Sites.

Authors:  Rachel E Ham; Austin R Smothers; Rui Che; Keegan J Sell; Congyue Annie Peng; Delphine Dean
Journal:  Microbiol Spectr       Date:  2022-05-12

7.  Mixed-methods process evaluation of a residence-based SARS-CoV-2 testing participation pilot on a UK university campus during the COVID-19 pandemic.

Authors:  H Blake; S Carlisle; L Fothergill; J Hassard; A Favier; J Corner; J K Ball; C Denning
Journal:  BMC Public Health       Date:  2022-08-02       Impact factor: 4.135

8.  Workforce Experiences of a Rapidly Established SARS-CoV-2 Asymptomatic Testing Service in a Higher Education Setting: A Qualitative Study.

Authors:  Holly Blake; Sarah Somerset; Ikra Mahmood; Neelam Mahmood; Jessica Corner; Jonathan K Ball; Chris Denning
Journal:  Int J Environ Res Public Health       Date:  2022-09-30       Impact factor: 4.614

9.  Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis.

Authors:  Lukas E Brümmer; Stephan Katzenschlager; Mary Gaeddert; Christian Erdmann; Stephani Schmitz; Marc Bota; Maurizio Grilli; Jan Larmann; Markus A Weigand; Nira R Pollock; Aurélien Macé; Sergio Carmona; Stefano Ongarello; Jilian A Sacks; Claudia M Denkinger
Journal:  PLoS Med       Date:  2021-08-12       Impact factor: 11.069

10.  Robotic RNA extraction for SARS-CoV-2 surveillance using saliva samples.

Authors:  Jennifer R Hamilton; Elizabeth C Stahl; Connor A Tsuchida; Enrique Lin-Shiao; C Kimberly Tsui; Kathleen Pestal; Holly K Gildea; Lea B Witkowsky; Erica A Moehle; Shana L McDevitt; Matthew McElroy; Amanda Keller; Iman Sylvain; Ariana Hirsh; Alison Ciling; Alexander J Ehrenberg; Bradley R Ringeisen; Garth Huberty; Fyodor D Urnov; Petros Giannikopoulos; Jennifer A Doudna
Journal:  PLoS One       Date:  2021-08-05       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.